María Victoria
Mateos Manteca
Profesora Titular de Universidad
María del Carmen
Chillón Santos
Investigadora desde null
Publicaciones en las que colabora con María del Carmen Chillón Santos (20)
2020
-
Biological and clinical significance of dysplastic hematopoiesis in patients with newly diagnosed multiple myeloma
Blood, Vol. 135, Núm. 26, pp. 2375-2387
-
Comparison of next-generation sequencing (NGS) and next-generation flow (NGF) for minimal residual disease (MRD) assessment in multiple myeloma
Blood Cancer Journal, Vol. 10, Núm. 10
-
Molecular profiling of immunoglobulin heavy-chain gene rearrangements unveils new potential prognostic markers for multiple myeloma patients
Blood Cancer Journal, Vol. 10, Núm. 2
2017
-
A Next-Generation Sequencing Strategy for Evaluating the Most Common Genetic Abnormalities in Multiple Myeloma
Journal of Molecular Diagnostics, Vol. 19, Núm. 1, pp. 99-106
-
Prediction of peripheral neuropathy in multiple myeloma patients receiving bortezomib and thalidomide: a genetic study based on a single nucleotide polymorphism array
Hematological Oncology, Vol. 35, Núm. 4, pp. 746-751
2015
-
Panobinostat as part of induction and maintenance for elderly patients with newly diagnosed acute myeloid leukemia: Phase Ib/II panobidara study
Haematologica, Vol. 100, Núm. 10, pp. 1294-1300
-
The predominant myeloma clone at diagnosis, CDR3 defined, is constantly detectable across all stages of disease evolution
Leukemia
2014
-
Critical evaluation of ASO RQ-PCR for minimal residual disease evaluation in multiple myeloma. A comparative analysis with flow cytometry
Leukemia, Vol. 28, Núm. 2, pp. 391-397
2013
-
Evaluating gene expression profiling by quantitative polymerase chain reaction to develop a clinically feasible test for outcome prediction in multiple myeloma
British Journal of Haematology, Vol. 163, Núm. 2, pp. 223-234
2010
-
BAALC is an important predictor of refractoriness to chemotherapy and poor survival in intermediate-risk acute myeloid leukemia (AML)
Annals of Hematology, Vol. 89, Núm. 5, pp. 453-458
2001
-
Gene scanning of VDJH-amplified segments is a clinically relevant technique to detect contaminating tumor cells in the apheresis products of multiple myeloma patients undergoing autologous peripheral blood stem cell transplantation
Bone Marrow Transplantation, Vol. 28, Núm. 7, pp. 665-672
2000
-
De novo methylation of tumor suppressor gene p16/INK4a is a frequent finding in multiple myeloma patients at diagnosis
Leukemia, Vol. 14, Núm. 1, pp. 183-187
-
Status of methylation of p16 gene in multiple myeloma: A comparative study of three methods for its detection
Clinical Biochemistry, Vol. 33, Núm. 5, pp. 415-418
-
The detection of contaminating clonal cells in apheresis products is related to response and outcome in multiple myeloma undergoing autologous peripheral blood stem cell transplantation
Leukemia, Vol. 14, Núm. 8, pp. 1493-1499
-
Two new 3' PML breakpoints in t(15;17)(q22;q21)-positive acute promyelocytic leukemia
Genes Chromosomes and Cancer, Vol. 27, Núm. 1, pp. 35-43
1999
-
Heteroduplex PCR analysis of rearranged immunoglobulin genes for clonality assessment in multiple myeloma
Haematologica, Vol. 84, Núm. 4, pp. 328-335
-
Heteroduplex analysis of VDJ amplified segments from rearranged IgH genes for clonality assessments in B-cell non-Hodgkin's lymphoma. A comparison between different strategies
Haematologica, Vol. 84, Núm. 9, pp. 779-784
-
Low frequency of the TEL/AML1 fusion gene in acute lymphoblastic leukaemia in Spain
British Journal of Haematology, Vol. 107, Núm. 3, pp. 667-669
1996
-
7. Biologia molecular en hemopatias malignas: 7.2. Aplicaciones clínicas, Estudio de los genes de las inmunoglobulinas (Igs) y receptor de célula T (RCT) y análisis molecular de las translocaciones cromosómicas
Sangre, Vol. 41, Núm. 4
-
Molecular biology in malignant blood diseases. Clinical applications. Study of immunoglobulin and T-cell receptor genes and molecular analysis of the translocations
Sangre, Vol. 41, Núm. 4, pp. 321-334